ID: ALA4291205

Max Phase: Preclinical

Molecular Formula: C152H258N52O36S

Molecular Weight: 3422.13

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CSCC[C@H](N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)O)C(C)C)[C@@H](C)O)C(C)C

Standard InChI:  InChI=1S/C152H258N52O36S/c1-79(2)71-101(193-136(229)105(74-86-33-15-14-16-34-86)195-134(227)102(72-80(3)4)192-135(228)103(73-81(5)6)196-141(234)119(85(12)205)200-139(232)109-45-29-66-201(109)143(236)107(76-114(159)209)197-140(233)117(82(7)8)198-137(230)106(77-116(211)212)191-121(214)89(156)56-70-241-13)133(226)188-93(37-19-22-59-155)132(225)199-118(83(9)10)145(238)202-67-30-44-108(202)138(231)179-84(11)120(213)181-98(52-54-112(157)207)131(224)194-104(75-87-48-50-88(206)51-49-87)122(215)178-78-115(210)180-90(38-23-60-172-147(160)161)123(216)182-91(35-17-20-57-153)124(217)183-92(36-18-21-58-154)125(218)184-94(39-24-61-173-148(162)163)126(219)185-96(41-26-63-175-150(166)167)128(221)189-99(53-55-113(158)208)130(223)187-95(40-25-62-174-149(164)165)127(220)186-97(42-27-64-176-151(168)169)129(222)190-100(43-28-65-177-152(170)171)142(235)203-68-31-46-110(203)144(237)204-69-32-47-111(204)146(239)240/h14-16,33-34,48-51,79-85,89-111,117-119,205-206H,17-32,35-47,52-78,153-156H2,1-13H3,(H2,157,207)(H2,158,208)(H2,159,209)(H,178,215)(H,179,231)(H,180,210)(H,181,213)(H,182,216)(H,183,217)(H,184,218)(H,185,219)(H,186,220)(H,187,223)(H,188,226)(H,189,221)(H,190,222)(H,191,214)(H,192,228)(H,193,229)(H,194,224)(H,195,227)(H,196,234)(H,197,233)(H,198,230)(H,199,225)(H,200,232)(H,211,212)(H,239,240)(H4,160,161,172)(H4,162,163,173)(H4,164,165,174)(H4,166,167,175)(H4,168,169,176)(H4,170,171,177)/t84-,85+,89-,90-,91-,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,109-,110-,111-,117-,118-,119-/m0/s1

Standard InChI Key:  NBFFYBCHNUZRPT-SEQQLKTDSA-N

Associated Targets(Human)

HEK-293T (167025 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

PA PA/PB1 (167 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Influenza A virus (11224 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDCK (10148 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 3422.13Molecular Weight (Monoisotopic): 3419.9677AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. D'Agostino I, Giacchello I, Nannetti G, Fallacara AL, Deodato D, Musumeci F, Grossi G, Palù G, Cau Y, Trist IM, Loregian A, Schenone S, Botta M..  (2018)  Synthesis and biological evaluation of a library of hybrid derivatives as inhibitors of influenza virus PA-PB1 interaction.,  157  [PMID:30142611] [10.1016/j.ejmech.2018.08.032]

Source